UdayR.PopatMD

PubMed

• Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
  Sairah Ahmed, Qaiser Bashir, Roland L Bassett Jr, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa Khouri, David Marin, ...> ;American Journal of Hematology. 2024 Apr 1
• Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.
  Supawee Saengboon, Julianne Chen, Gabriela Rondon, Jim S Im, Elizabeth J Shpall, Stefan O Ciurea, Uday R Popat, Jeremy Leon Ramdial, Qaiser Bashir, Amin Majid Alousi, ...> ;Blood Advances. 2024 Mar 23
• ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells.
  Benigno C Valdez, Bin Yuan, David Murray, Jeremy L Ramdial, Uday Popat, Yago Nieto, Borje S Andersson> ;Oncotarget. 2024 Mar 14
• Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.
  Curtis Marcoux, Rima M Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday Popat, Betul Oran, Amanda Olson, Qaiser Bashir, Mu...> ;Blood Advances. 2024 Mar 12
• Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplan...
  Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, Vijaya Raj Bhatt, Josu de la Fuente, Aloysius Ho, Leslie Kean, Jong Wook Lee, Isabel Sánchez-Ortega, Bipin N Savani, ...> ;Bone Marrow Transplantation. 2024 Mar 5
• 5 citations
  Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19B cell tumors: a phase 1/2 trial.
  David Marin, Ye Li, Rafet Basar, Hind Rafei, May Daher, Jinzhuang Dou, Vakul Mohanty, Merve Dede, Yago Nieto, Nadima Uprety, Sunil Acharya, Enli Liu, Jeffrey Wilson, P...> ;Nature Medicine. 2024 Mar 1
• Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center pha...
  Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, Denái R Milton, Alison M Gulbis, Koji Sasaki, Nitin Jain, Nicholas J Short, Tapan Kadia, May Daher, Hind Rafei, Jin S...> ;American Journal of Hematology. 2024 May 1
• Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
  Malek, A., Al-Juhaishi, T., Milton, D., Ramdial, J., Daher, M., Olson, A., Srour, S., Alatrash, G., Oran, B., Mehta, R., Khouri, I., Bashir, Q., Shah, N., Ciurea, S., ...> ;Bone Marrow Transplantation. 2024 Feb 14
• Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
  Pasvolsky, O., Saliba, R., Popat, U., Alousi, A., Mehta, R., Yeh, J., Al-Atrash, G., Adeel, M., Ramdial, J., Marin, D., Rondon, G., Kebriaei, P., Champlin, R., Daver, ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 3
• The Role of Outpatient Physical Medicine and Rehabilitation in a Multidisciplinary Prehabilitation Program for Older Adults before Allogeneic Hematopoietic Stem Cell T...
  Cheng, J., Collaco, A., Szewcyzk, N., Obaisi, O., Yadav, R., Gupta, E., Fu, J., Bruera, E., Popat, U., Ngo-Huang, A.> ;American Journal of Physical Medicine & Rehabilitation. 2024 Jan 8
• Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
  Pasvolsky, O., Bassett, R., Ghanem, S., Cuglievan, B., Tewari, P., Hosing, C., Srour, S., Ramdial, J., Mahadeo, K., Khazal, S., Petropoulos, D., Popat, U., Qazilbash, ...> ;BMC Cancer. 2023 Dec 20
• 2 citations
  Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group.
  Kröger, N., Bacigalupo, A., Barbui, T., Ditschkowski, M., Gagelmann, N., Griesshammer, M., Gupta, V., Hamad, N., Harrison, C., Hernandez-Boluda, J., Koschmieder, S., J...> ;The Lancet. Haematology. 2024 Jan 1
• 1 citations
  Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning.
  Jacinth Joseph, Samer A Srour, Denái R Milton, Jeremy L Ramdial, Neeraj Y Saini, Amanda L Olson, Qaiser Bashir, Betul Oran, Amin M Alousi, Chitra Hosing, Muzaffar H Qa...> ;Transplantation and Cellular Therapy. 2023 Dec 1
• 1 citations
  Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.
  Uday R Popat, Oren Pasvolsky, Roland Bassett Jr, Rohtesh S Mehta, Amanda Olson, Julianne Chen, Amin M Alousi, Gheath Al-Atrash, Qaiser Bashir, Alison M Gulbis, Chitra ...> ;Blood Advances. 2023 Oct 24
• 1 citations
  High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
  Hanan Alkhaldi, Alec Reinhardt, Melissa Barnett, Suprateek Kundu, Chitra Hosing, Jeremy Ramdial, Neeraj Saini, Samer Srour, Amin Alousi, Partow Kebriaei, Uday Popat, M...> ;Transplantation and Cellular Therapy. 2023 Nov 1
• 1 citations
  Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell ...
  Fevzi F Yalniz, Uri Greenbaum, Oren Pasvolsky, Denái R Milton, Rashmi Kanagal-Shamanna, Jeremy Ramdial, Samer Srour, Rohtesh Mehta, Amin Alousi, Uday R Popat, Yago Nie...> ;Transplantation and Cellular Therapy. 2024 Feb 1
• 1 citations
  Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
  Alexandre Bazinet, Hagop Kantarjian, Naszrin Arani, Uday Popat, Alex Bataller, Koji Sasaki, Courtney D DiNardo, Naval Daver, Musa Yilmaz, Hussein A Abbas, Nicholas J S...> ;American Journal of Hematology. 2023 Sep 1
• A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Co...
  Edwin J Ostrin, Nicholas L Rider, Amin M Alousi, Ehsan Irajizad, Liang Li, Qian Peng, Sang T Kim, Lara Bashoura, Muhammad H Arain, Laila Z Noor, Nikul Patel, Rohtesh M...> ;Immunohorizons. 2023 Jun 1
• Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.
  Taha Al-Juhaishi, Yingjun Wang, Denái R Milton, Zijun Y Xu-Monette, Elias Jabbour, May Daher, Jin S Im, Qaiser Bashir, Swaminathan P Iyer, David Marin, Amanda L Olson,...> ;Bone Marrow Transplantation. 2023 Sep 1
• 2 citations
  The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients.
  Sarah A Wall, Rebecca Olin, Vijaya Bhatt, Saurabh Chhabra, Pashna Munshi, Eileen Hacker, Shahrukh Hashmi, Hailey Hassel, Dianna Howard, Reena Jayani, Richard Lin, Shan...> ;Transplantation and Cellular Therapy. 2023 Oct 1
• 7 citations
  Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation.
  Nicholas J Short, Faustine Ong, Farhad Ravandi, Graciela Nogueras-Gonzalez, Tapan M Kadia, Naval Daver, Courtney D DiNardo, Marina Konopleva, Gautam Borthakur, Betul O...> ;Blood Advances. 2023 Jul 25
• Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant.
  Yago Nieto, Oren Pasvolsky, Roland Bassett, Sassine Ghanem, Branko Cuglievan, Priti Tewari, Chitra Hosing, Samer Srour, Jeremy Ramdial, Kris Mahadeo, Sajad Khazal, Dem...> ;Research Square. 2023 Feb 7
• 4 citations
  Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
  Curtis Marcoux, David Marin, Jeremy Ramdial, Gheath AlAtrash, Amin M Alousi, Betul Oran, Partow Kebriaei, Uday R Popat, Katayoun Rezvani, Richard E Champlin, Elizabeth...> ;American Journal of Hematology. 2023 May 1
• 1 citations
  Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant.
  An Ngo-Huang, Rachel Ombres, Rima M Saliba, Nicholas Szewczyk, LaToya Adekoya, Tacara N Soones, Jill Ferguson, Rhodora C Fontillas, Alison M Gulbis, Chitra Hosing, Par...> ;JCO Oncology Practice. 2023 Mar 1
• Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells.
  Benigno C Valdez, Bin Yuan, David Murray, Jeremy Leon Ramdial, Yago Nieto, Uday Popat, Xiaowen Tang, Borje S Andersson> ;Frontiers in Oncology. 2023 Jan 1
• Join now to see all

Journal Articles

• Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
  Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
• Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...  
  Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature

Abstracts/Posters

• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Achievement of Complete Remission (CR) with Measurable Residual Disease (MRD) Negativity Is Highly Prognostic in Patients (pts) with Relapsed or Refractory (R/R) Acute...
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantat...
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Do...
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Final Results of Phase 2 Clinical Trial of LCL161, a Novel Oral SMAC Mimetic/IAP Antagonist, for Patients with Intermediate to High Risk Myelofibrosis
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
  Uday Popat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Post-transplant cyclophosphamide in matched and haploidentical transplant recipients receiving myeloablative timed sequential busulfan conditioning regimen: Results of... 
  2019 ASCO Annual Meeting - 6/1/2019
• Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hematopoietic Cell Transplant -Composite Risk (HCT-CR) - a Novel Prognostic Model to Predict Transplant Outcomes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all